Mark Jeremy Hunt1, Beryl Raynaud, Rene Garcia. 1. Université de Nice-Sophia Antipolis, Laboratoire de Neurobiologie et Psychopathologie, Nice, France. mhunt@nencki.gov.pl
Abstract
BACKGROUND: In humans, subanesthetic doses of ketamine and recovery from ketamine anesthesia are associated with psychotic-like behavior. In rodents, ketamine produces hyperactivity, stereotypies, and abnormal social interaction used to model certain features of schizophrenia. Increasing evidence has implicated aberrant activity in the nucleus accumbens (NAc) with the pathophysiology of schizophrenia. METHODS: Here, we examined the effect of an IP injection of ketamine (10, 25, 50, and 200 mg/kg) and d-amphetamine (3 mg/kg) on local field potentials in the rodent NAc. Locomotor activity was recorded simultaneously. RESULTS: Spontaneous high-frequency oscillations (HFO) (140-180 Hz) were present in local field potentials recorded from the NAc. Ketamine dose-dependently induced rapid and substantial increases in HFO that correlated with behavioral hyperactivity. Similarly, large increases in HFO occurred during recovery from ketamine anesthesia. In contrast, d-amphetamine, which induced locomotor activity, produced only small increases in HFO. CONCLUSIONS: We propose that ketamine-induced abnormal increases in HFO form part of the complex neurological changes in this model of schizophrenia. Ketamine-induced increases in HFO, although sharing similar temporal dynamics to hyperactivity, may not be functionally related to increased movement.
BACKGROUND: In humans, subanesthetic doses of ketamine and recovery from ketamine anesthesia are associated with psychotic-like behavior. In rodents, ketamine produces hyperactivity, stereotypies, and abnormal social interaction used to model certain features of schizophrenia. Increasing evidence has implicated aberrant activity in the nucleus accumbens (NAc) with the pathophysiology of schizophrenia. METHODS: Here, we examined the effect of an IP injection of ketamine (10, 25, 50, and 200 mg/kg) and d-amphetamine (3 mg/kg) on local field potentials in the rodent NAc. Locomotor activity was recorded simultaneously. RESULTS: Spontaneous high-frequency oscillations (HFO) (140-180 Hz) were present in local field potentials recorded from the NAc. Ketamine dose-dependently induced rapid and substantial increases in HFO that correlated with behavioral hyperactivity. Similarly, large increases in HFO occurred during recovery from ketamine anesthesia. In contrast, d-amphetamine, which induced locomotor activity, produced only small increases in HFO. CONCLUSIONS: We propose that ketamine-induced abnormal increases in HFO form part of the complex neurological changes in this model of schizophrenia. Ketamine-induced increases in HFO, although sharing similar temporal dynamics to hyperactivity, may not be functionally related to increased movement.
Authors: Ingeborg H Hansen; Claus Agerskov; Lars Arvastson; Jesper F Bastlund; Helge B D Sørensen; Kjartan F Herrik Journal: Eur J Neurosci Date: 2019-04-01 Impact factor: 3.386
Authors: Alexandra Ioppi Zugno; Felipe Damázio Pacheco; Josiane Budni; Mariana Bittencourt de Oliveira; Lara Canever; Alexandra Stephanie Heylmann; Patrícia Gomes Wessler; Flávia da Rosa Silveira; Gustavo Antunes Mastella; Cinara Ludwig Gonçalves; Karoline V Freitas; Adalberto Alves de Castro; Emilio L Streck; João Quevedo Journal: Metab Brain Dis Date: 2015-04-30 Impact factor: 3.584
Authors: Larissa de Oliveira; Daiane B Fraga; Renata D De Luca; Leila Canever; Fernando V Ghedim; Maria Paula P Matos; Emilio L Streck; João Quevedo; Alexandra I Zugno Journal: Metab Brain Dis Date: 2011-02-18 Impact factor: 3.584
Authors: L Elliot Hong; Ann Summerfelt; Robert W Buchanan; Patricio O'Donnell; Gunvant K Thaker; Martin A Weiler; Adrienne C Lahti Journal: Neuropsychopharmacology Date: 2009-11-04 Impact factor: 7.853
Authors: Francisco J Flores; ShiNung Ching; Katharine Hartnack; Amanda B Fath; Patrick L Purdon; Matthew A Wilson; Emery N Brown Journal: J Neural Eng Date: 2015-08-13 Impact factor: 5.379
Authors: Zhihao Mao; Shengxi He; Christopher Mesnard; Paul Synowicki; Yuning Zhang; Lucy Chung; Alex I Wiesman; Tony W Wilson; Daniel T Monaghan Journal: Brain Res Date: 2019-11-28 Impact factor: 3.252
Authors: Maryam Ardalan; Betina Elfving; Ali H Rafati; Monireh Mansouri; Carlos A Zarate; Aleksander A Mathe; Gregers Wegener Journal: Eur Neuropsychopharmacol Date: 2020-01-20 Impact factor: 4.600
Authors: Tahir Hakami; Nigel C Jones; Elena A Tolmacheva; Julien Gaudias; Joseph Chaumont; Michael Salzberg; Terence J O'Brien; Didier Pinault Journal: PLoS One Date: 2009-08-25 Impact factor: 3.240